← Back to Search

Colorectal Cancer Screening Program for Underserved Communities

N/A
Recruiting
Led By Juliana M Kling
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
No first-degree family history of colorectal cancer who were diagnosed under age 60
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to study completion, up to 30 days
Awards & highlights

Study Summary

This trial is testing a program to provide free, home-based colorectal cancer screenings to Black and underserved communities in the Phoenix metropolitan area.

Who is the study for?
This trial is for individuals aged 45 or older in the Phoenix area, particularly from Black and underserved communities. Eligible participants should not have a family history of colorectal cancer diagnosed before age 60, no recent GI symptoms, no colonoscopy in the past 5 years, and no FIT test within the last year.Check my eligibility
What is being tested?
The study tests if providing free fecal immunochemical testing (FIT), educational materials on colorectal screening, and patient navigation can improve cancer screening rates in these communities.See study design
What are the potential side effects?
Since this trial involves non-invasive interventions like education and FIT tests rather than medication or surgery, side effects are minimal to none. However, discomfort or emotional distress due to discussions about personal health may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have current GI or rectal symptoms.
Select...
No immediate family member had colorectal cancer before 60.
Select...
I have never had colorectal cancer or colon polyps.
Select...
I am 45 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to study completion, up to 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to study completion, up to 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colorectal cancer disparities seen in people of color and minority populations

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (FIT, education, questionnaire, patient navigation)Experimental Treatment4 Interventions
Participants receive free FIT tests in conjunction with education on colorectal cancer screening. Participants undergo self-collect FIT and mail the sample to Mayo Clinic Lab for processing. Participants also complete a questionnaire about colorectal cancer screening and healthcare. Participants receive FIT test results through Mayo Clinic nursing support and participants with a positive test are followed up by a patient navigator to discuss next steps and consultation with a gastroenterologist to review their results.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,692 Previous Clinical Trials
40,929,426 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,230 Previous Clinical Trials
3,771,604 Total Patients Enrolled
Juliana M KlingPrincipal InvestigatorMayo Clinic

Media Library

Fecal Immunochemical Test Clinical Trial Eligibility Overview. Trial Name: NCT05447923 — N/A
Colorectal Cancer Research Study Groups: Screening (FIT, education, questionnaire, patient navigation)
Colorectal Cancer Clinical Trial 2023: Fecal Immunochemical Test Highlights & Side Effects. Trial Name: NCT05447923 — N/A
Fecal Immunochemical Test 2023 Treatment Timeline for Medical Study. Trial Name: NCT05447923 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being enrolled in this experiment?

"Affirmative. Clinicaltrials.gov's records show that this clinical trial, initially posted on May 11th 2022 is currently recruiting patients. 450 participants are being sought from a single medical centre."

Answered by AI

Are there any vacancies available for enrolment in this investigation?

"The details hosted on clinicaltrials.gov reveal that the trial is still actively recruiting participants, with its inception having been initially posted at 11th May 2022 and last updated on 1st July 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
2022. "Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05447923.
All > Colorectal Cancer Glendale
~150 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top